שווי מתואם לחוב ומזומנים Polyrizon (PLRZ)

This price chart for Polyrizon Ltd (PLRZ) illustrates the company's valuation, which currently stands at 6.20. The business relies on the creation of antiviral nasal barriers, utilizing long-term agreements with chemists to ensure stable supplies and high profits. Production is automated via robotic systems that guarantee sterile filling. Patent protection for hydrogels creates a technological barrier, although limited distribution constrains final margins.

Enterprise Value is used to assess the financial margin of safety for Polyrizon Ltd (PLRZ), combining the market value of shares with net debt to determine the actual price for a full buyout of the business. By analyzing the company's aggregate asset valuation, an investor can see the capitalization of the intellectual property for Inertia gel barriers, whose patents and stable seasonal demand ensure the resilience of the enterprise value.